Login / Signup

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.

Haidar Salimi DafsariPablo Martinez-MartinAlexandra RizosMaja TrostMaria Gabriela Dos Santos GhilardiPrashanth ReddyAnna SauerbierJan Niklas Petry-SchmelzerMilica KrambergerRobbert W K BorgemeesterMichael T BarbeKeyoumars AshkanMonty SilverdaleJulian EvansPer OdinErich Talamoni FonoffGereon R FinkTove HenriksenGeorg EbersbachZvezdan PirtošekVeerle Visser-VandewalleAngelo AntoniniLars TimmermannKallol Ray Chaudhurinull null
Published in: Movement disorders : official journal of the Movement Disorder Society (2019)
This is the first comparison of quality of life, nonmotor. and motor outcomes in PD patients undergoing STN-DBS, IJLI, and APO in a real-life cohort. Distinct effect profiles were identified for each treatment option. Our results highlight the importance of holistic nonmotor and motor symptoms assessments to personalize treatment choices. © 2019 International Parkinson and Movement Disorder Society.
Keyphrases
  • parkinson disease
  • deep brain stimulation
  • patients undergoing
  • low dose
  • type diabetes
  • skeletal muscle